Clinical trials
Phase 3 Purpura, Thrombocytopenic, Idiopathic trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 3 |
| Novartis Pharmaceuticals | 2 |
| Rigel Pharmaceuticals | 2 |
| Takeda | 2 |
| argenx | 2 |
| CSL Limited | 1 |
| Eisai Inc. | 1 |
| Principia Biopharma, a Sanofi Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 14 |
| Thrombocytopenia | 4 |
| Hemorrhage | 3 |
| Purpura | 3 |
| Purpura, Thrombocytopenic | 3 |
| Autoimmune Diseases | 2 |
| Blood Platelet Disorders | 2 |
| Cytopenia | 2 |
| Hematologic Diseases | 2 |
| Hemorrhagic Disorders | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.